AsOf

Recorded or changed on this day 2026-11-08

44,951–45,000 of 46,535 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 3,952,974,000 United States dollar
Vertex Pharmaceuticals total assets: 3,952,974,000 United States dollar, claim clm_4E19B710DABA · ended · superseded by clm_30C87D2C1CBD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · research and development · 1,829,537,000 United States dollar
Vertex Pharmaceuticals research and development: 1,829,537,000 United States dollar, claim clm_4E727A17F6D8 · ended · superseded by clm_A31B2D7AAD7A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 238,963,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 238,963,000 United States…, claim clm_4F43AE81E1E8 · ended · superseded by clm_D9114AAA14BA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 66,924,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 66,924,000 United States dollar, claim clm_4F89C70F30F6 · ended · superseded by clm_94A2F9498133 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · operating income · 2,332,000 United States dollar
Vertex Pharmaceuticals operating income: 2,332,000 United States dollar, claim clm_4F9C4EE9CB90 · ended · superseded by clm_A3A048BBF066 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 52,707,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 52,707,000 United States dollar, claim clm_4FCE9FD3FD98 · ended · superseded by clm_1A65A038D644 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 542,545,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 542,545,000 United States dollar, claim clm_51A871DDB6C2 · ended · superseded by clm_84EBB48920A6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 454,947,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 454,947,000 United States…, claim clm_5202D9005278 · ended · superseded by clm_0D1ACE4B2058 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 260,037,894 shares
Vertex Pharmaceuticals shares outstanding: 260,037,894 shares, claim clm_5240C50AF834 · ended · superseded by clm_DB51B55830F5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 138,421,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 138,421,000 United States dollar, claim clm_52B14B1D462C · ended · superseded by clm_E49939D6DEDB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 11,933,500,000 United States dollar
Vertex Pharmaceuticals total equity: 11,933,500,000 United States dollar, claim clm_53E6658C91B5 · ended · superseded by clm_61A9104D30AD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 202,202,912 shares
Vertex Pharmaceuticals shares outstanding: 202,202,912 shares, claim clm_5547C6BF3A52 · ended · superseded by clm_115794095037 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 579,762,000 United States dollar
Vertex Pharmaceuticals total equity: 579,762,000 United States dollar, claim clm_56187F563316 · ended · superseded by clm_46A87149904E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 248,438,127 shares
Vertex Pharmaceuticals shares outstanding: 248,438,127 shares, claim clm_56628A376B7F · ended · superseded by clm_AC9B824300B5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 2,374,800,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 2,374,800,000 United States dollar, claim clm_56F24DCACD81 · ended · superseded by clm_12CF2E7419A7 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · SIC industry · Pharmaceutical Preparations (2834)
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 1,031,400,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 1,031,400,000 United States dollar, claim clm_58ABF4712193 · ended · superseded by clm_5C5F8DB6F575 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · net income · -445,028,000 United States dollar
Vertex Pharmaceuticals net income: -445,028,000 United States dollar, claim clm_59D5E0CC1F00 · ended · superseded by clm_E0C813E29FDB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 448,528,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 448,528,000 United States…, claim clm_5AE1EF5CC196 · ended · superseded by clm_92B502813AA4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 1,106,300,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 1,106,300,000 United States dollar, claim clm_5B1D0BBCD832 · ended · superseded by clm_E6727C1C16C9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 1,654,202,000 United States dollar
Vertex Pharmaceuticals total assets: 1,654,202,000 United States dollar, claim clm_5B82DB4B1ACF · ended · superseded by clm_C3D8BF48EB7E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 1,099,800,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 1,099,800,000 United States dollar, claim clm_5C5F8DB6F575 · ended · superseded by clm_466B90DBA1DE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 3,333,900,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 3,333,900,000 United States dollar, claim clm_600A80B3AFE0 · ended · superseded by clm_30E62BBC7C14 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 379,091,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 379,091,000 United States…, claim clm_6053DA9FFA3A · ended · superseded by clm_E4FC8BA4267A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 7,514,553,000 United States dollar
Vertex Pharmaceuticals total assets: 7,514,553,000 United States dollar, claim clm_606AE4761405 · ended · superseded by clm_8E39CFC66249 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,433,993,000 United States dollar
Vertex Pharmaceuticals total assets: 2,433,993,000 United States dollar, claim clm_60B4E50AFB70 · ended · superseded by clm_1B7DAA0B3049 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · quarterly operating income · 712,900,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,406,086,000 United States dollar
Vertex Pharmaceuticals total assets: 2,406,086,000 United States dollar, claim clm_6195F192CBDE · ended · superseded by clm_34CC74560F05 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 13,029,600,000 United States dollar
Vertex Pharmaceuticals total equity: 13,029,600,000 United States dollar, claim clm_61A9104D30AD · ended · superseded by clm_6D580D76E517 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 172,878,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 172,878,000 United States dollar, claim clm_61C96CE7DB96 · ended · superseded by clm_D6C88602928F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 10,504,000,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 10,504,000,000 United States dollar, claim clm_63A9B4EA0EFC · ended · superseded by clm_DA9B9E142C37 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 99,333,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 99,333,000 United States dollar, claim clm_63C6CFD02CA4 · ended · superseded by clm_EB1B0B642262 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 257,683,184 shares
Vertex Pharmaceuticals shares outstanding: 257,683,184 shares, claim clm_63DBD5A352EB · ended · superseded by clm_1BAB99487696 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 1,026,400,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 1,026,400,000 United States dollar, claim clm_641582E9BBA4 · ended · superseded by clm_BE04B4442DA0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -198,606,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -198,606,000 United States dollar, claim clm_64459540A52F · ended · superseded by clm_E074FD6EA019 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 253,718,831 shares
Vertex Pharmaceuticals shares outstanding: 253,718,831 shares, claim clm_663C199EF289 · ended · superseded by clm_B7B98F7F000A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 276,808,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 276,808,000 United States dollar, claim clm_6686B23D1227 · ended · superseded by clm_3837B5FA4621 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · net income · -754,626,000 United States dollar
Vertex Pharmaceuticals net income: -754,626,000 United States dollar, claim clm_6694DF685051 · ended · superseded by clm_D6D7CB158831 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -169,573,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -169,573,000 United States dollar, claim clm_66CCBB904B9A · ended · superseded by clm_8982B813454B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 640,799,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 640,799,000 United States dollar, claim clm_66E56361C26E · ended · superseded by clm_7A545FD3F361 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 9,869,200,000 United States dollar
Vertex Pharmaceuticals revenue: 9,869,200,000 United States dollar, claim clm_6755CB60586A · ended · superseded by clm_9011721F7C0D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 24,036,700,000 United States dollar
Vertex Pharmaceuticals total assets: 24,036,700,000 United States dollar, claim clm_68305CEE2495 · ended · superseded by clm_D95598CEB876 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,718,823,000 United States dollar
Vertex Pharmaceuticals total assets: 2,718,823,000 United States dollar, claim clm_68D80A12D2B9 · ended · superseded by clm_16575A0C10F3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 4,831,332,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 4,831,332,000 United States dollar, claim clm_6915B8D4ABB5 · ended · superseded by clm_69B23FF91BEB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 5,358,087,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 5,358,087,000 United States dollar, claim clm_69B23FF91BEB · ended · superseded by clm_0A0A75CC866D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 203,194,222 shares
Vertex Pharmaceuticals shares outstanding: 203,194,222 shares, claim clm_69DF2085CFCB · ended · superseded by clm_995698503836 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -64,525,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -64,525,000 United States dollar, claim clm_6A661CF6BB52 · ended · superseded by clm_E8FAE6590B2B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 650,096,000 United States dollar
Vertex Pharmaceuticals total equity: 650,096,000 United States dollar, claim clm_6AC662175277 · ended · superseded by clm_ABDC2E967578 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 210,263,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 210,263,000 United States dollar, claim clm_6AE5A6A85AD2 · ended · superseded by clm_0E72F2D69F41 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 1,763,100,000 United States dollar
Vertex Pharmaceuticals total assets: 1,763,100,000 United States dollar, claim clm_6B7C068E138D · ended · superseded by clm_0364D2508EA1 · 1 source (1 primary) · conf 0.95

What the statuses mean